We are live on ! Find out more
PROK icon

ProKidney
PROK

90 hedge funds and large institutions have $223M invested in ProKidney in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 7

7% more funds holding

Funds holding: 84 → 90 (+6)

0% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 15

0.56% less ownership

Funds ownership: 89.97% → 89.42% (-0.56%)

1% less capital invested

Capital invested by funds: $225M → $223M (-$2.48M)

Holders
90
Holders Change
+6
Holders Change %
+7.14%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
15
Reduced
15
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RIA
RP Investment Advisors
Ontario, Canada
+$5.33M
2
LCM
LH Capital Markets
New York
+$4.94M
3
CAC
Cowen and Company
New York
+$3.18M
4
SC
Sculptor Capital
New York
+$1.64M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.17M

Top Sellers

Rank Fund Capital Flow
1
BCM
BlueCrest Capital Management
Jersey
-$5M
2
MS
Maven Securities
Jersey
-$4.9M
3
AC
Athanor Capital
New York
-$3.92M
4
SSA
Schonfeld Strategic Advisors
New York
-$3.92M
5
GCL
Glazer Capital LLC
New York
-$1.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
76
Weiss Asset Management
Massachusetts
$292K -$5.93K -600 -2%
WCA
77
Waratah Capital Advisors
Ontario, Canada
$253K -$253K -25,556 -50%
BFM
78
Boothbay Fund Management
New York
$226K +$17.8K +1,804 +9%
Verition Fund Management
79
Verition Fund Management
Connecticut
$212K – – –
FTCM
80
Fir Tree Capital Management
New York
$198K – – –
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
$198K – – –
WAM
82
Wolverine Asset Management
Illinois
$191K -$90K -9,100 -32%
CAPTRUST Financial Advisors
83
CAPTRUST Financial Advisors
North Carolina
$99K – – –
Morgan Stanley
84
Morgan Stanley
New York
$94K +$25.7K +2,600 +38%
CCM
85
Condor Capital Management
New Jersey
$57K – – –
PCM
86
PenderFund Capital Management
British Columbia, Canada
$32K +$12.2K +1,230 +95%
AA
87
Ancora Advisors
Ohio
$23K – – –
UBS Group
88
UBS Group
Switzerland
$7K +$7.46K +755 New
TRCT
89
Tower Research Capital (TRC)
New York
$5K +$5.3K +536 New
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4.21K +$336 +34 +0%
MS
91
Maven Securities
Jersey
– -$4.9M -500,000 Closed
AC
92
Athanor Capital
New York
– -$3.92M -400,000 Closed
SSA
93
Schonfeld Strategic Advisors
New York
– -$3.92M -400,000 Closed
JP Morgan Chase
94
JP Morgan Chase
New York
– -$1.47M -150,000 Closed
CCFM
95
Cohen & Co Financial Management
New York
– -$994K -101,414 Closed
OAC
96
OMERS Administration Corp
Ontario, Canada
– -$392K -40,000 Closed
Parallax Volatility Advisers
97
Parallax Volatility Advisers
California
– -$369K -37,685 Closed
1 2 3
4

PROK Hedge Fund Activity: Q4 2021 in Review

90 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q4 2021, worth a combined $223M — down 1.1% from $225M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new PROK positions and 7 closed out — a net gain of 6 holders — while 15 added to existing stakes and 15 trimmed.

The largest buyer was RP Investment Advisors, opening a new position worth an estimated $5.33M. The largest seller was BlueCrest Capital Management, cutting an estimated $5M.

  • 90 institutional investors held ProKidney (PROK) as of Q4 2021, up from 84 in Q3 2021.
  • Funds reported $223M of ProKidney stock for Q4 2021, down 1.1% quarter-over-quarter.
  • 13 funds opened new ProKidney positions in Q4 2021 and 7 closed out, a net change of +6 holders.
  • The largest ProKidney buyer in Q4 2021 was RP Investment Advisors, an estimated $5.33M added.
  • The largest ProKidney seller in Q4 2021 was BlueCrest Capital Management, an estimated $5M sold.

Based on aggregated 13F filings for Q4 2021.